Low-concentration atropine for controlling myopia onset and progression in East Asia
Authors:
Open Access
- 7 December 2024
- journal article
- research article
- Published by Elsevier in Asia-Pacific Journal of Ophthalmology
- Vol. 13 (6) , 100122
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Effect of 0.01% atropine eye drops combined with different optical treatments to control low myopia in Chinese childrenContact Lens and Anterior Eye, 2024
- Four-Year Progression of Myopic Maculopathy in Children and Adolescents With High MyopiaJAMA Ophthalmology, 2024
- Topical Atropine for Childhood Myopia ControlJAMA Ophthalmology, 2024
- Effect of Repeated Low-level Red Light on Myopia Prevention Among Children in China With PremyopiaJAMA Network Open, 2023
- Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in ChildrenJAMA, 2023
- Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trialContact Lens and Anterior Eye, 2022
- The Association of Choroidal Thickening by Atropine With Treatment Effects for Myopia: Two-Year Clinical Trial of the Low-concentration Atropine for Myopia Progression (LAMP) StudyAmerican Journal of Ophthalmology, 2022
- Evaluation of an Optical Defocus Treatment for Myopia Progression Among Schoolchildren During the COVID-19 PandemicJAMA Network Open, 2022
- Pediatric rhegmatogenous retinal detachment: predictors of anatomic and functional successInternational Ophthalmology, 2021
- Low-Dose Atropine for Myopia ControlJAMA Ophthalmology, 2018